Funding and technology rights answer different questions
A research team turning a sensor into a product may be incorporating, applying for support, seeking a Shenzhen manufacturing partner and approaching its first customer at the same time. A funding notification is progress, but it does not necessarily resolve every prerequisite for product development. The company still needs to identify who owns the technology and which document permits the intended activities.
This article concerns CUHK in Hong Kong, not CUHK-Shenzhen or a uniform policy across Hong Kong universities. Teams at other institutions should consult their own technology-transfer office and agreements.
Section 9.1 of CUHK's 2027/28 TSSSU guidelines says a company adopting CUHK IP should obtain an appropriate licence through KTO before using it to develop a product. Outside IP also requires appropriate permission. Funding agreements are addressed separately: a funding notification is not a substitute for technology rights. CUHK TSSSU guidelines
If the founders developed it, why discuss a licence?
Inventive contribution, IP ownership and a company's right to use technology are separate questions. A founder's central role in the research does not, on its own, establish that a newly incorporated company owns or may use every relevant result.
CUHK's IP policy, section 9.6(b), provides for a licence to a startup on separately negotiated terms. The policy contains specific arrangements and exceptions for different people and outputs; it should not be reduced to a claim that all student work belongs to the university. Here, the focus is technology established as university-owned and intended for use by the company. CUHK IP policy, administratively revised in August 2025
A useful first step is a concise technology inventory: patent or application identifiers, software versions, required technical materials and known third-party components. It is a discussion document for KTO, not a self-issued ownership determination. A laboratory project name alone may not explain the rights the company needs.
Negotiation is not the same as an effective agreement
CUHK KTO's public FAQ describes a process involving review, commercial and legal negotiation, drafting and approval. Financial terms are considered case by case. An inventor-founded company should not assume it will receive an exclusive licence. CUHK KTO licensing FAQ
For founders, the operational distinction is between discussing rights and holding them. An introductory email, a proposed term sheet, a revised agreement and an executed, effective licence are different stages. Fundraising materials should describe the stage supported by the documents. Translation must not turn a qualified Chinese statement into an unconditional English promise.
| Document or status | What it helps establish | What still needs a separate check |
|---|---|---|
| Incorporation and ownership records | The company and its participants | Its authority to use the technology |
| Funding or incubation documents | The scope and conditions of support | Whether a technology licence is separate |
| Draft licence terms | Matters under negotiation | Approval, execution and effectiveness |
| Effective licence | Contractual rights and obligations | Whether the actual product and activities fit |
This is an editorial way of organising records, not a new university application requirement.
An option's title does not explain its permitted uses
If the team holds an option, letter of intent or evaluation arrangement, do not simply rename it a commercial licence. Ask KTO and appropriate advisers what the actual provisions permit: internal assessment, external trials, manufacturing, sales or providing technology to a partner? When does the arrangement end, how is an option exercised and what conditions remain?
This article does not assign CUHK options a standard duration, fee or exclusivity, or assume every option grants only negotiation rights. The institution, technology and agreement matter. Even an unpaid trial warrants checking the proposed activities; absence of revenue is not a reason to omit the question.
Make the rights question concrete for a Shenzhen partner
Consider an illustrative scenario, not a reported project: a Hong Kong research company asks a Shenzhen partner to develop a sensor enclosure and assemble a small batch. Identify which designs the company developed independently, which university technology must be used within a licence, and whether the supplier needs restricted source code or process information.
Have the proposed handover reviewed before setting access permissions and the work scope. Calling a partner a contract manufacturer does not explain why it should receive an entire technical package. Nor does a licence to one technology establish that every IP question about the finished product is resolved. Third-party rights, certification and cross-border matters may need separate attention.
Engineering planning can proceed alongside this work, while external commitments stay aligned with confirmed conditions. Unauthorised or unresolved activities can be identified as prerequisites, with time and cost allowed for their resolution.
Where Jimhang Capital can join the discussion
For teams connecting Hong Kong research with Greater Bay Area industry, Jimhang Capital can start with a non-confidential product overview, the current authorisation status, engineering needs and the next validation objective. That discussion neither grants university rights nor implies a CUHK partnership or an investment decision.
An initial approach need not include restricted source code, research data or an entire private licence. A one-page description can explain the product, confirmed conditions and the next problem to solve. Academic-founder role boundaries and patent review before a public demonstration remain separate questions, not matters settled by a technology licence alone.
Contact Justin Zhan · About Jimhang Capital · Justin Zhan profile
Sources reviewed on 20 October 2026. AI-assisted editorial analysis for the Jimhang Capital website, not a verbatim statement by Justin Zhan or CUHK's opinion. This is not legal or investment advice. Ownership, licence scope, third-party rights and cross-border arrangements require review by the relevant rights holders, institution and professional advisers.